Oxford Biodynamics PLC (LSE:OBD) — Market Cap & Net Worth
Market Cap & Net Worth: Oxford Biodynamics PLC (OBD)
Oxford Biodynamics PLC (LSE:OBD) has a market capitalization of $86.14K (GBX708.00 Million) as of June 19, 2026. Listed on the LSE stock exchange, this UK-based company holds position #31328 globally and #1142 in its home market, demonstrating a -12.23% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Oxford Biodynamics PLC's stock price GBX0.17 by its total outstanding shares 4290910967 (4.29 Billion). Review Oxford Biodynamics PLC (OBD) total liabilities to assess the company's total debt and financial obligations.
Oxford Biodynamics PLC Market Cap History: 2016 to 2026
Oxford Biodynamics PLC's market capitalization history from 2016 to 2026. Data shows change from $79.10 Million to $86.14K (-51.35% CAGR).
Index Memberships
Oxford Biodynamics PLC is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
FTSE AIM All Share Index
FTAI
|
$939.61 Million | 0.01% | #375 of 722 |
Weight: Oxford Biodynamics PLC's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Oxford Biodynamics PLC Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Oxford Biodynamics PLC's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.10x
Oxford Biodynamics PLC's market cap is 0.10 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $79.10 Million | $1.09 Million | -$1.73 Million | 72.50x | N/A |
| 2017 | $89.54 Million | $1.18 Million | -$3.80 Million | 75.69x | N/A |
| 2018 | $109.64 Million | $1.19 Million | -$1.95 Million | 92.44x | N/A |
| 2019 | $61.08 Million | $907.00K | -$2.80 Million | 67.35x | N/A |
| 2020 | $43.33 Million | $456.00K | -$4.31 Million | 95.03x | N/A |
| 2021 | $20.23 Million | $341.00K | -$6.68 Million | 59.33x | N/A |
| 2022 | $8.95 Million | $154.00K | -$6.71 Million | 58.14x | N/A |
| 2023 | $14.62 Million | $510.00K | -$10.83 Million | 28.66x | N/A |
| 2024 | $783.12K | $636.00K | -$11.57 Million | 1.23x | N/A |
| 2025 | $112.25K | $1.09 Million | -$11.15 Million | 0.10x | N/A |
Competitor Companies of OBD by Market Capitalization
Companies near Oxford Biodynamics PLC in the global market cap rankings as of June 19, 2026.
Key companies related to Oxford Biodynamics PLC by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #131 globally with a market cap of $174.56 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #189 globally with a market cap of $125.14 Billion USD.
- IDEXX Laboratories Inc (NASDAQ:IDXX): Ranked #621 globally with a market cap of $44.18 Billion USD.
- LONZA GROUP UNSP.ADR 1/10 (F:LO3A): Ranked #664 globally with a market cap of $41.04 Billion USD ( €35.10 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #131 | Thermo Fisher Scientific Inc | NYSE:TMO | $174.56 Billion | $464.61 |
| #189 | Danaher Corporation | NYSE:DHR | $125.14 Billion | $177.17 |
| #621 | IDEXX Laboratories Inc | NASDAQ:IDXX | $44.18 Billion | $562.09 |
| #664 | LONZA GROUP UNSP.ADR 1/10 | F:LO3A | $41.04 Billion | €54.50 |
Oxford Biodynamics PLC Historical Marketcap From 2016 to 2026
Between 2016 and today, Oxford Biodynamics PLC's market cap moved from $79.10 Million to $ 86.14K, with a yearly change of -51.35%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | GBX86.14K | -23.26% |
| 2025 | GBX112.25K | -85.67% |
| 2024 | GBX783.12K | -94.64% |
| 2023 | GBX14.62 Million | +63.27% |
| 2022 | GBX8.95 Million | -55.74% |
| 2021 | GBX20.23 Million | -53.31% |
| 2020 | GBX43.33 Million | -29.06% |
| 2019 | GBX61.08 Million | -44.29% |
| 2018 | GBX109.64 Million | +22.45% |
| 2017 | GBX89.54 Million | +13.20% |
| 2016 | GBX79.10 Million | -- |
End of Day Market Cap According to Different Sources
On Jun 19th, 2026 the market cap of Oxford Biodynamics PLC was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $86.14K USD |
| MoneyControl | $86.14K USD |
| MarketWatch | $86.14K USD |
| marketcap.company | $86.14K USD |
| Reuters | $86.14K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Oxford Biodynamics PLC
Oxford BioDynamics Plc, together with its subsidiaries, operates as a biotechnology company that y developing, and commercializing precision medicine tests for life-changing diseases in the United States and the United Kingdom. The company provides EpiSwitch CiRT (Checkpoint inhibitor Response Test), a blood test that predicts an individual patient's therapeutic response to checkpoint inhibitor i… Read more